DaVita (DVA) — insider trading
Health Care
DaVita (DVA) has 18 reported SEC Form 4 insider transactions in our data, including 5 open-market sales among the most recent 18 (latest 2026-06-16).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-16 | Rodriguez Javier | Director, Officer (Chief Executive Officer) | Open-market sale | 39,407 | $209.28 | $8.25M | Form 4 |
| 2026-06-15 | Rodriguez Javier | Director, Officer (Chief Executive Officer) | Open-market sale | 30,000 | $209.50 | $6.29M | Form 4 |
| 2026-06-15 | Waters Kathleen Alyce | Officer (Chief Legal & Pub. Affairs Off) | Open-market sale | 6,455 | $209.17 | $1.35M | Form 4 |
| 2026-06-15 | Waters Kathleen Alyce | Officer (Chief Legal & Pub. Affairs Off) | Open-market sale | 8,950 | $207.84 | $1.86M | Form 4 |
| 2026-05-26 | YALE PHYLLIS R | Director | Bona fide gift | 5,038 | $0.00 | $0 | Form 4 |
| 2026-05-15 | HEARTY JAMES O | Officer (Chief Compliance Officer) | Open-market sale | 15,000 | $193.98 | $2.91M | Form 4 |
| 2026-05-15 | Hollar Jason M. | Director | Grant / award / vesting | 250 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Schechter Adam H | Director | Grant / award / vesting | 250 | $0.00 | $0 | Form 4 |
| 2026-05-15 | DESOER BARBARA J | Director | Grant / award / vesting | 250 | $0.00 | $0 | Form 4 |
| 2026-05-15 | YALE PHYLLIS R | Director | Grant / award / vesting | 250 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Arway Pamela M | Director | Grant / award / vesting | 250 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Schoppert Wendy Lee | Director | Grant / award / vesting | 250 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Moore Gregory J. | Director | Grant / award / vesting | 250 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Pullin Dennis W | Director | Grant / award / vesting | 250 | $0.00 | $0 | Form 4 |
| 2026-05-14 | HEARTY JAMES O | Officer (Chief Compliance Officer) | Option exercise / conversion (derivative) | 5,784 | $0.00 | $0 | Form 4 |
| 2026-05-14 | HEARTY JAMES O | Officer (Chief Compliance Officer) | Shares withheld for taxes / exercise cost | 1,117 | $198.10 | $221.3K | Form 4 |
| 2026-05-14 | HEARTY JAMES O | Officer (Chief Compliance Officer) | Disposition to the issuer | 3,231 | $198.10 | $640.1K | Form 4 |
| 2026-05-14 | HEARTY JAMES O | Officer (Chief Compliance Officer) | Option exercise / conversion | 5,784 | $110.63 | $639.9K | Form 4 |
Ask the chat about DVA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: DaVita (DVA).
Last updated 2026-06-16 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.